Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to characterize the safety and tolerability of avelumab in
combination with Laser Interstitial Thermal Therapy (LITT) for blood barrier disruption in
patients with recurrent glioblastoma.